About L2MTech
L2MTech is a company based in Bonn (Germany) founded in 2017. It operates as a B2B. L2MTech offers products and services including PearlFlow, LimusTrack, FlexiTrack-018 PTA Catheter, FlexiTrack-035 PTA Catheter, and PearlFlow NS. L2MTech operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Bonn, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name L2mtech India Private Limited
- Date of Incorporation 19 Oct, 2019
- Jurisdiction Ratlam, Madhya Pradesh, India
-
Annual Revenue
$221.35 K (USD)0as on Mar 31, 2022
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of L2MTech
L2MTech offers a comprehensive portfolio of products and services, including PearlFlow, LimusTrack, FlexiTrack-018 PTA Catheter, FlexiTrack-035 PTA Catheter, and PearlFlow NS.
Self-Expandable Nitinol Peripheral Stent for artery disease treatment.
Paclitaxel Eluting Coronary Balloon to minimize restenosis risks.
Peripheral catheter for Infrapopliteal arteries interventions.
Designed for multiple peripheral intervention challenges.
Nitinol Peripheral Stent system addressing artery disease.
Coronary Balloon with excipient for enhanced drug uptake.
Funding Insights of L2MTech
Detailed funding history for L2MTech
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by L2MTech
Investment portfolio details for L2MTech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - L2MTech
Detailed financials for L2MTech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
L2mtech Comparisons
Peer comparison for L2MTech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of L2MTech
L2MTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of L2MTech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on L2mtech
Complete news archive for L2MTech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about L2MTech
L2MTech was founded in 2017.
L2MTech is headquartered in Bonn, Germany. It is registered at Bonn, North Rhine-westphalia, Germany.
Annual revenue of L2MTech is $221.35K as on Mar 31, 2022.
L2MTech GmbH is a multinational company based in Bonn, Germany, specializing in designing, developing, manufacturing, and distributing medical devices. They focus on products such as stents and catheters for treating peripheral artery disease and other cardiovascular conditions. The company serves healthcare establishments worldwide through B2B channels, emphasizing innovative solutions for medical interventions.
L2MTech's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
L2MTech offers PearlFlow, LimusTrack, FlexiTrack-018 PTA Catheter, FlexiTrack-035 PTA Catheter, and 2 more products and services.